Cargando…
Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways
BACKGROUND: Our previous study demonstrated that the expression of miR-16 was downregulated in the cell and animal models of atherosclerosis (AS), a main contributor to coronary artery disease (CAD). Overexpression of miR-16 inhibited the formation of foam cells by exerting anti-inflammatory roles....
Autores principales: | Wang, Manman, Li, Jiao, Cai, Jiageng, Cheng, Lijun, Wang, Xuewen, Xu, Pengjuan, Li, Guangping, Liang, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391121/ https://www.ncbi.nlm.nih.gov/pubmed/32775445 http://dx.doi.org/10.1155/2020/8504238 |
Ejemplares similares
-
MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4
por: LIANG, XUE, et al.
Publicado: (2016) -
MicroRNA-124 inhibits macrophage cell apoptosis via targeting p38/MAPK signaling pathway in atherosclerosis development
por: Liang, Xue, et al.
Publicado: (2020) -
PRDM16 Upregulation Induced by MicroRNA-448 Inhibition Alleviates Atherosclerosis via the TGF-β Signaling Pathway Inactivation
por: Liu, Dongxing, et al.
Publicado: (2020) -
Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis
por: Bai, Qianqian, et al.
Publicado: (2022) -
Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis
por: Jahangir, Zainab, et al.
Publicado: (2018)